JP Stock MarketDetailed Quotes

4527 Rohto Pharmaceutical

Watchlist

3112.0
+52.0+1.70%

20min DelayTrading Jun 17 10:26 JST

709.97BMarket Cap23.02P/E (Static)

Rohto Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

Total revenue

13.48%270.84B

11.66%69.68B

11.14%73.29B

14.88%66.7B

17.06%61.17B

19.54%238.66B

12.18%62.4B

24.43%65.95B

19.21%58.06B

23.49%52.26B

Cost of revenue

12.16%113.55B

12.86%29.81B

10.52%29.83B

13.25%28.51B

12.09%25.4B

21.28%101.24B

13.93%26.42B

24.51%27B

23.27%25.17B

24.58%22.66B

Gross profit

14.45%157.29B

10.78%39.87B

11.56%43.46B

16.13%38.19B

20.87%35.77B

18.29%137.42B

10.93%35.99B

24.37%38.96B

16.28%32.89B

22.67%29.6B

Operating expense

13.32%117.23B

14.56%35.08B

9.53%29.16B

14.46%28.51B

14.93%24.48B

18.71%103.46B

14.39%30.62B

22.54%26.63B

21.19%24.91B

17.67%21.3B

Staff costs

7.52%22.01B

----

11.37%20.47B

----

Selling and administrative expenses

16.68%54.22B

----

21.92%46.47B

----

-Selling and marketing expense

16.68%54.22B

----

21.92%46.47B

----

Research and development costs

21.01%13.39B

----

26.60%11.07B

----

Depreciation and amortization

3.59%2.42B

----

10.70%2.34B

----

-Depreciation

1.58%1.99B

----

18.12%1.96B

----

-Amortization

13.84%436M

----

-16.19%383M

----

Other operating expenses

8.98%25.19B

----

16.73%23.12B

----

Operating profit

17.92%40.05B

-10.75%4.79B

15.95%14.3B

21.33%9.67B

36.13%11.29B

17.04%33.96B

-5.41%5.37B

28.51%12.33B

3.20%7.97B

37.67%8.3B

Net non-operating interest income (expenses)

85.59%1.33B

54.89%412M

150.35%353M

160.71%292M

37.76%270M

495.83%715M

818.92%266M

138.98%141M

100.00%112M

366.67%196M

Non-operating interest income

58.32%1.52B

34.17%428M

100.00%424M

99.44%355M

24.90%316M

161.41%962M

243.01%319M

103.85%212M

83.51%178M

241.89%253M

Non-operating interest expense

-20.65%196M

-69.81%16M

0.00%71M

-4.55%63M

-19.30%46M

-0.40%247M

-59.23%53M

57.78%71M

60.98%66M

78.13%57M

Net investment income

102.39%933M

4,530.00%463M

3.99%-265M

1.27%478M

0.78%257M

20.37%461M

103.70%10M

-263.31%-276M

9,340.00%472M

-46.76%255M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

-274.18%-1.01B

-129.18%-164M

-4,120.00%-603M

53.33%-161M

-122.32%-77M

172.31%577M

345.41%562M

103.23%15M

-56.82%-345M

200.00%345M

Income from associates and other participating interests

-259.67%-289M

-1,067.57%-358M

-121.25%-17M

-14.29%12M

48.00%74M

26.57%181M

5.71%37M

-54.02%80M

193.33%14M

198.04%50M

Special income (charges)

29.91%-246M

2,833.33%246M

-24.49%-1.54B

-63.95%-1.39B

238.93%207M

-715.79%-351M

96.99%-9M

Less:Restructuring and mergern&acquisition

----

--0

----

Less:Other special charges

----

219.53%153M

--0

----

Less:Write off

--0

----

24.24%246M

-2,833.33%-246M

-32.34%1.39B

----

-68.47%198M

-96.99%9M

Other non-operating income (expenses)

901.59%505M

-126.19%-190M

133.67%263M

-12.50%252M

-64.98%180M

-125.61%-63M

-61.54%-84M

-642.36%-781M

700.00%288M

335.59%514M

Income before tax

21.08%41.52B

3.88%4.95B

19.71%14.03B

26.23%10.3B

26.87%12.24B

23.02%34.29B

11.49%4.76B

22.99%11.72B

6.74%8.16B

50.09%9.65B

Income tax

28.79%10.12B

-50.00%84M

36.45%4.32B

40.74%2.73B

15.58%2.99B

17.56%7.86B

-46.15%168M

-5.55%3.17B

42.47%1.94B

55.75%2.59B

Net income

18.79%31.39B

5.88%4.86B

13.49%9.71B

21.70%7.57B

31.03%9.25B

24.74%26.43B

15.98%4.59B

38.49%8.55B

-0.99%6.22B

48.09%7.06B

Net income continuous operations

18.79%31.4B

5.85%4.86B

13.51%9.71B

21.71%7.57B

31.01%9.25B

24.74%26.43B

16.04%4.6B

38.48%8.55B

-1.00%6.22B

48.11%7.06B

Noncontrolling interests

778.85%457M

158.62%85M

34.91%143M

209.09%68M

133.33%161M

-13.33%52M

-154.39%-145M

21.84%106M

100.00%22M

263.16%69M

Net income attributable to the company

17.28%30.94B

0.82%4.78B

13.24%9.56B

21.01%7.5B

30.02%9.09B

24.85%26.38B

18.00%4.74B

38.72%8.45B

-1.15%6.2B

47.21%6.99B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

17.28%30.94B

0.82%4.78B

13.24%9.56B

21.01%7.5B

30.02%9.09B

24.85%26.38B

18.00%4.74B

38.72%8.45B

-1.15%6.2B

47.21%6.99B

Gross dividend payment

Basic earnings per share

17.29%135.61

0.82%20.95

13.27%41.92

21.01%32.89

30.02%39.85

24.85%115.62

18.00%20.78

38.69%37.01

-1.15%27.18

47.21%30.65

Diluted earnings per share

17.28%135.21

0.77%20.88

13.25%41.8

21.03%32.8

30.01%39.73

24.85%115.29

18.00%20.72

38.73%36.91

-1.15%27.1

47.21%30.56

Dividend per share

22.73%27

25.00%15

20.00%12

22.22%22

14.29%12

33.33%10

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022
Total revenue	13.48%270.84B	11.66%69.68B	11.14%73.29B	14.88%66.7B	17.06%61.17B	19.54%238.66B	12.18%62.4B	24.43%65.95B	19.21%58.06B	23.49%52.26B
Cost of revenue	12.16%113.55B	12.86%29.81B	10.52%29.83B	13.25%28.51B	12.09%25.4B	21.28%101.24B	13.93%26.42B	24.51%27B	23.27%25.17B	24.58%22.66B
Gross profit	14.45%157.29B	10.78%39.87B	11.56%43.46B	16.13%38.19B	20.87%35.77B	18.29%137.42B	10.93%35.99B	24.37%38.96B	16.28%32.89B	22.67%29.6B
Operating expense	13.32%117.23B	14.56%35.08B	9.53%29.16B	14.46%28.51B	14.93%24.48B	18.71%103.46B	14.39%30.62B	22.54%26.63B	21.19%24.91B	17.67%21.3B
Staff costs	7.52%22.01B	----	----	----	----	11.37%20.47B	----	----	----	----
Selling and administrative expenses	16.68%54.22B	----	----	----	----	21.92%46.47B	----	----	----	----
-Selling and marketing expense	16.68%54.22B	----	----	----	----	21.92%46.47B	----	----	----	----
Research and development costs	21.01%13.39B	----	----	----	----	26.60%11.07B	----	----	----	----
Depreciation and amortization	3.59%2.42B	----	----	----	----	10.70%2.34B	----	----	----	----
-Depreciation	1.58%1.99B	----	----	----	----	18.12%1.96B	----	----	----	----
-Amortization	13.84%436M	----	----	----	----	-16.19%383M	----	----	----	----
Other operating expenses	8.98%25.19B	----	----	----	----	16.73%23.12B	----	----	----	----
Operating profit	17.92%40.05B	-10.75%4.79B	15.95%14.3B	21.33%9.67B	36.13%11.29B	17.04%33.96B	-5.41%5.37B	28.51%12.33B	3.20%7.97B	37.67%8.3B
Net non-operating interest income (expenses)	85.59%1.33B	54.89%412M	150.35%353M	160.71%292M	37.76%270M	495.83%715M	818.92%266M	138.98%141M	100.00%112M	366.67%196M
Non-operating interest income	58.32%1.52B	34.17%428M	100.00%424M	99.44%355M	24.90%316M	161.41%962M	243.01%319M	103.85%212M	83.51%178M	241.89%253M
Non-operating interest expense	-20.65%196M	-69.81%16M	0.00%71M	-4.55%63M	-19.30%46M	-0.40%247M	-59.23%53M	57.78%71M	60.98%66M	78.13%57M
Net investment income	102.39%933M	4,530.00%463M	3.99%-265M	1.27%478M	0.78%257M	20.37%461M	103.70%10M	-263.31%-276M	9,340.00%472M	-46.76%255M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	-274.18%-1.01B	-129.18%-164M	-4,120.00%-603M	53.33%-161M	-122.32%-77M	172.31%577M	345.41%562M	103.23%15M	-56.82%-345M	200.00%345M
Income from associates and other participating interests	-259.67%-289M	-1,067.57%-358M	-121.25%-17M	-14.29%12M	48.00%74M	26.57%181M	5.71%37M	-54.02%80M	193.33%14M	198.04%50M
Special income (charges)	0	0	0	29.91%-246M	2,833.33%246M	-24.49%-1.54B	-63.95%-1.39B	238.93%207M	-715.79%-351M	96.99%-9M
Less:Restructuring and mergern&acquisition	----	----	----	----	----	--0	----	----	----	----
Less:Other special charges	----	----	----	----	----	219.53%153M	--0	--0	----	----
Less:Write off	--0	----	----	24.24%246M	-2,833.33%-246M	-32.34%1.39B	----	----	-68.47%198M	-96.99%9M
Other non-operating income (expenses)	901.59%505M	-126.19%-190M	133.67%263M	-12.50%252M	-64.98%180M	-125.61%-63M	-61.54%-84M	-642.36%-781M	700.00%288M	335.59%514M
Income before tax	21.08%41.52B	3.88%4.95B	19.71%14.03B	26.23%10.3B	26.87%12.24B	23.02%34.29B	11.49%4.76B	22.99%11.72B	6.74%8.16B	50.09%9.65B
Income tax	28.79%10.12B	-50.00%84M	36.45%4.32B	40.74%2.73B	15.58%2.99B	17.56%7.86B	-46.15%168M	-5.55%3.17B	42.47%1.94B	55.75%2.59B
Net income	18.79%31.39B	5.88%4.86B	13.49%9.71B	21.70%7.57B	31.03%9.25B	24.74%26.43B	15.98%4.59B	38.49%8.55B	-0.99%6.22B	48.09%7.06B
Net income continuous operations	18.79%31.4B	5.85%4.86B	13.51%9.71B	21.71%7.57B	31.01%9.25B	24.74%26.43B	16.04%4.6B	38.48%8.55B	-1.00%6.22B	48.11%7.06B
Noncontrolling interests	778.85%457M	158.62%85M	34.91%143M	209.09%68M	133.33%161M	-13.33%52M	-154.39%-145M	21.84%106M	100.00%22M	263.16%69M
Net income attributable to the company	17.28%30.94B	0.82%4.78B	13.24%9.56B	21.01%7.5B	30.02%9.09B	24.85%26.38B	18.00%4.74B	38.72%8.45B	-1.15%6.2B	47.21%6.99B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	17.28%30.94B	0.82%4.78B	13.24%9.56B	21.01%7.5B	30.02%9.09B	24.85%26.38B	18.00%4.74B	38.72%8.45B	-1.15%6.2B	47.21%6.99B
Gross dividend payment
Basic earnings per share	17.29%135.61	0.82%20.95	13.27%41.92	21.01%32.89	30.02%39.85	24.85%115.62	18.00%20.78	38.69%37.01	-1.15%27.18	47.21%30.65
Diluted earnings per share	17.28%135.21	0.77%20.88	13.25%41.8	21.03%32.8	30.01%39.73	24.85%115.29	18.00%20.72	38.73%36.91	-1.15%27.1	47.21%30.56
Dividend per share	22.73%27	25.00%15	0	20.00%12	0	22.22%22	14.29%12	0	33.33%10	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall